Search Results 1131-1140 of 39169 for Two-phase

  1. Crizotinib in Treating Patients with Stage IB-IIIA Non-small Cell Lung Cancer that has been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial) - Mayo Clinic

    Study phase. 3. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  2. A Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects With Myeloid/Lymphoid Neoplasms With FGFR1 Rearrangement - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  3. Chronic kidney disease - Symptoms and causes - Mayo Clinic

    Kidney disease stage, eGFR, mL/min, Kidney function. Stage 1, 90 or above, Healthy kidney function. Stage 2, 60 to 89, Mild loss of kidney function. Stage 3a ...

  4. PET Scan Imaging in Assessing Response in Patients with Esophageal Cancer Receiving Combination Chemotherapy - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  5. A Novel Vaccine (EO2463) as Monotherapy and in Combination, for Treatment of Patients With Indolent Non-Hodgkin Lymphoma - Mayo Clinic

    Study phase. 1/2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase ( ...

  6. Cholangiocarcinoma (bile duct cancer) - Symptoms and causes - Mayo Clinic

    Diabetes. People who have type 1 or 2 diabetes may have an increased risk of cholangiocarcinoma. Certain inherited conditions. Some DNA changes passed from ...

  7. A Study to Evaluate MN-166 (Ibudilast) for 12 Months Followed by an Open-label Extension for 6 Months in Patients with Amyotrophic Lateral Sclerosis (ALS) - Mayo Clinic

    Study phase. 2/3. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase ( ...

  8. S0820, Adenoma and Second Primary Prevention Trial - Mayo Clinic

    Study phase. 3. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  9. Emricasan, A Caspase Inhibitor, For Treatment Of Subjects With Decompensated NASH Cirrhosis - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  10. Obstetrics and Gynecology Clinical Trials - Medical Professionals

    ... phase 2 dose (RP2D) 1.1.2 To evaluate the safety and tolerability of this combination in a dose expansion cohort in patients with uterine serous carcinoma.